ARVN Stock Summary and Trading Ideas (Arvinas | NASDAQ:ARVN)

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

What symbol and exchange does Arvinas shares trade?

Arvinas trades on the NASDAQ stock market under the symbol ARVN.

What is Arvinas stock price doing today?

As of September 17, 2026, ARVN stock price climbed to $8.31 with 493,657 million shares trading.

What is Arvinas's Beta?

ARVN has a beta of 1.39, meaning it tends to be more sensitive to market movements. ARVN has a correlation of 0.13 to the broad based SPY ETF.

How much is Arvinas worth?

ARVN has a market cap of $543.36 million. This is considered a Small Cap stock.

How much money does Arvinas make?

Last quarter Arvinas reported $250 million in Revenue and $2.58 earnings per share. This beat revenue expectation by $193 million and exceeded earnings estimates by $2.84.

What is the highest and lowest price Arvinas traded in the last 3 year period?

In the last 3 years, ARVN traded as high as $53.08 and as low as $5.90.

What are the top ETFs holding Arvinas?

The top ETF exchange traded funds that ARVN belongs to (by Net Assets): VTI, IWM, XPH, VXF, IWN.

Is Arvinas (ARVN) a good investment?

ARVN has underperformed the market in the last year with a price return of +8.8% while the SPY ETF gained +16.7%. However, in the short term, ARVN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.0% vs +1.9% return in SPY. But in the last 2 weeks, ARVN shares have been beat by the market, returning -13.3% compared to an SPY return of -0.3%.

What are the support and resistance levels for Arvinas (ARVN)?

ARVN support price is $7.92 and resistance is $8.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARVN shares will trade within this expected range on the day.